Providing Africans with affordable health care could be realized if pharmaceutical products were produced on the African continent, writes Marthe van der Wolf for Voice of America. The continent faces many challenges before it will be able produce its own medicines.
African and Chinese delegations came together last week at the Roundtable on China-Africa Health Cooperation in Botswana to discuss how Africa can start producing health care products on the continent. This could help African countries provide their citizens with a stable supply of quality medicines.
Feng Zhao of the African Development Bank said that producing locally could bring many benefits for the continent. "If you look at the pharmaceutical sector now, the size is very small compared to the global overall size. Africa is now less than 1 percent of the global share," noted Mr Zhao, adding: "It has a great potential to grow, the average growth rate is expected to be more than 10%." The sector would also create high quality jobs and bring more technology to the continent.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze